Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study-Reference-Cited by-同舟云学术

Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study

Published:2021-10 Issue: Volume:156 Page:70-82
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kahan Zsuzsanna,Gil-Gil Miguel^ORCID,Ruiz-Borrego Manuel,Carrasco Eva,Ciruelos Eva,Muñoz Montserrat,Bermejo Begoña^ORCID,Margeli Mireia,Antón Antonio,Casas Maribel,Csöszi Tibor,Murillo Laura,Morales Serafín,Calvo Lourdes^ORCID,Lang Istvan,Alba Emilio,de la Haba-Rodriguez Juan,Ramos Manuel^ORCID,López Isabel Álvarez,Gal-Yam Einav,Garcia-Palomo Andrés,Alvarez Elena,González-Santiago Santiago,Rodríguez César A.,Servitja Sonia^ORCID,Corsaro Massimo,Rodrigálvarez Graciela,Zielinski Christoph,Martín Miguel

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6;Toogood;J Med Chem,2005

2. Palbociclib and letrozole in advanced breast cancer;Finn;N Engl J Med,2016

3. Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

4. Palbociclib in hormone-receptor-positive advanced breast cancer;Turner;N Engl J Med,2015

5. Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial;Harbeck;Ann Oncol,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast Cancer;Geburtshilfe und Frauenheilkunde;2024-09

2. Identifying drivers of first-line HR+/HER2− metastatic breast cancer treatment choices;Future Oncology;2024-06-04

3. Therapeutic Effects of CDK4/6 Inhibitors in Gastric and Colonic Metastases From Breast Cancer: A Case Report;Cureus;2024-01-22

4. Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study;European Journal of Cancer;2024-01

5. Prevalence of Cognitive Impairment in Patients Receiving 5- Fu Containing Chemotherapy- a Systematic Review and Meta-analysis;2023-11-01